Total Payments
$693.72
2024 Payments
$378.87
Companies
6
Transactions
28
Medicare Patients
2,826
Medicare Billing
$170,601
Payment Breakdown by Category
Food & Beverage$693.72 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $693.72 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $319.51 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $215.38 | 16 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $57.12 | 3 | $0 (2024) |
| Insmed, Inc. | $50.00 | 1 | $0 (2024) |
| GENZYME CORPORATION | $35.47 | 2 | $0 (2023) |
| Mylan Specialty L.P. | $16.24 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $378.87 | 15 | AstraZeneca Pharmaceuticals LP ($153.09) |
| 2023 | $231.78 | 8 | AstraZeneca Pharmaceuticals LP ($129.83) |
| 2022 | $61.15 | 4 | GlaxoSmithKline, LLC. ($31.65) |
| 2021 | $21.92 | 1 | AstraZeneca Pharmaceuticals LP ($21.92) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: IMMUNOLOGY | ||||||
| 05/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: IMMUNOLOGY | ||||||
| 04/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: RESPIRATORY | ||||||
| 04/04/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: IMMUNOLOGY | ||||||
| 02/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: IMMUNOLOGY | ||||||
| 02/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: RESPIRATORY | ||||||
| 01/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), TEZSPIRE | Food and Beverage | In-kind items and services | $153.09 | General |
| Category: Respiratory | ||||||
| 01/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/06/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Immunology | ||||||
| 09/14/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: RESPIRATORY | ||||||
| 07/14/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Respiratory | ||||||
| 07/12/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/22/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: IMMUNOLOGY | ||||||
| 06/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Immunology | ||||||
| 03/09/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), AIRSUPRA, TEZSPIRE | Food and Beverage | In-kind items and services | $115.01 | General |
| Category: Respiratory | ||||||
| 10/27/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: RESPIRATORY | ||||||
| 09/29/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 549 | 675 | $99,675 | $39,436 |
| 2022 | 5 | 642 | 731 | $99,895 | $39,761 |
| 2021 | 6 | 778 | 917 | $114,815 | $49,877 |
| 2020 | 7 | 857 | 1,023 | $100,535 | $41,528 |
Total Patients
2,826
Total Services
3,346
Medicare Billing
$170,601
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 263 | 344 | $65,360 | $26,293 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 137 | $18,495 | $7,139 | 38.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 48 | 55 | $7,425 | $2,605 | 35.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 28 | 29 | $5,510 | $2,102 | 38.2% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 61 | 83 | $2,075 | $990.89 | 47.8% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 24 | 27 | $810.00 | $304.98 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 179 | 204 | $38,760 | $16,033 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 236 | 265 | $35,775 | $14,423 | 40.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 60 | 66 | $12,540 | $4,633 | 36.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 69 | 72 | $9,720 | $3,104 | 31.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 98 | 124 | $3,100 | $1,569 | 50.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 289 | 332 | $41,500 | $18,161 | 43.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 190 | 222 | $39,960 | $17,690 | 44.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 100 | 115 | $14,375 | $5,798 | 40.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 58 | 64 | $11,520 | $4,703 | 40.8% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2021 | 128 | 171 | $4,275 | $2,185 | 51.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,185 | $1,341 | 42.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 218 | 253 | $40,437 | $16,527 | 40.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 322 | 374 | $41,108 | $15,708 | 38.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 119 | 147 | $10,130 | $5,247 | 51.8% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2020 | 114 | 162 | $4,050 | $1,990 | 49.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 26 | 26 | $3,140 | $1,437 | 45.8% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2020 | 28 | 29 | $870.00 | $341.16 | 39.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 30 | 32 | $800.00 | $276.64 | 34.6% |
About Ginger Davis, CNP
Ginger Davis, CNP is a Nurse Practitioner healthcare provider based in Lancaster, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/14/2015. The National Provider Identifier (NPI) number assigned to this provider is 1255720264.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ginger Davis, CNP has received a total of $693.72 in payments from pharmaceutical and medical device companies, with $378.87 received in 2024. These payments were reported across 28 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($693.72).
As a Medicare-enrolled provider, Davis has provided services to 2,826 Medicare beneficiaries, totaling 3,346 services with total Medicare billing of $170,601. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Lancaster, OH
- Active Since 01/14/2015
- Last Updated 09/30/2016
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1255720264
Products in Payments
- AIRSUPRA (Drug) $153.09
- BREZTRI (Drug) $115.01
- TRELEGY ELLIPTA (Drug) $104.58
- NUCALA (Biological) $93.73
- DUPIXENT (Biological) $92.59
- Arikayce (Drug) $50.00
- FASENRA (Biological) $36.59
- AREXVY (Drug) $17.07
- YUPELRI (Drug) $16.24
- TEZSPIRE (Biological) $14.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Lancaster
Emily Fox, Crnp, CRNP
Nurse Practitioner — Payments: $7,068
Nurse Practitioner $7,068
Priscilla Carroll, Fnp-Bc, FNP-BC
Nurse Practitioner — Payments: $6,992
Nurse Practitioner $6,992
Mr. Jerome Marcos, Np, NP
Nurse Practitioner — Payments: $5,592
Nurse Practitioner $5,592
Jena Leisher, Crnp, CRNP
Nurse Practitioner — Payments: $4,607
Nurse Practitioner $4,607
Deborah Rice, Np, NP
Nurse Practitioner — Payments: $3,780
Nurse Practitioner $3,780
Mrs. Emily Young, Apn, APN
Nurse Practitioner — Payments: $3,706
Nurse Practitioner $3,706